Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 1r subcomponent (C1r) is a serine protease and a key protein in the classical pathway of the complement system. It forms part of the C1 complex along with C1q and C1s. Upon activation by C1q binding to immune complexes, C1r activates C1s, initiating a proteolytic cascade that leads to opsonization, inflammation, and cell lysis. Mutations in C1R are associated with Ehlers-Danlos syndrome, and deficiencies in complement components can contribute to autoimmune diseases.
Proteolytic cleavage and activation of complement components (e.g., C1s, C4, C2)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component 1r subcomponent.